静脉-动脉体外膜氧合支持期间拔管的临床获益
倾向评分重叠权重分析后,拔管组30天内无ICU天数显著高于未拔管组(22天 vs 18天,p=0.036),呼吸机相关性肺炎和30天全因死亡率无差异。次要分析全体641例结果一致,拔管组无ICU天数更多且30天死亡风险更低。结论认为ECMO支持期间拔管安全可行,与更多无ICU天数相关。
要点
- 拔管组30天内无ICU天数显著多于未拔管组(22天[11-26] vs 18天[7-25],p=0.036)。
- 拔管组与未拔管组呼吸机相关性肺炎(OR 0.96,95%CI 0.51-1.82)和30天全因死亡率(5% vs 17%,HR 0.54,95%CI 0.19-1.59)无显著差异。
- 入院时较高的简化急性生理评分II与拔管概率降低相关(OR 0.97,95%CI 0.95-0.99,p=0.008)。
适用人群与场景
- 接受静脉-动脉体外膜氧合支持的难治性心源性休克患者,来自三家ICU(1500张床位的三级大学医院)。
- 主要分析纳入344例成功撤除ECMO的患者;次要分析纳入全体641例静脉-动脉ECMO支持患者。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 拔管患者中25%因呼吸、神经或血流动力学原因需要紧急再插管。
研究设计与关键结果
- 研究类型:回顾性队列研究,采用倾向评分重叠权重分析;设置:三家ICU;主要分析人群:344例成功撤机的静脉-动脉ECMO患者。
- 主要分析:拔管组与未拔管组呼吸机相关性肺炎(OR 0.96,95%CI 0.51-1.82,p=0.90)和30天全因死亡率(5% vs 17%,HR 0.54,95%CI 0.19-1.59,p=0.27)无显著差异。
- 次要分析(全体641例):拔管组无ICU天数更多(18天[0-24] vs 0天[0-18],p<0.001),30天死亡风险更低(HR 0.45,95%CI 0.29-0.71,p=0.001)。
- 拔管预测因素:入院时较高的简化急性生理评分II与拔管概率降低相关(OR 0.97,95%CI 0.95-0.99,p=0.008);心脏外科ICU插管与拔管概率增加相关(OR 3.14,95%CI 1.21-8.14,p=0.018)。
证据类型、等级与局限
- 证据类型:回顾性队列研究,采用倾向评分重叠权重分析;局限:原文未明确提及,但设计本身为回顾性、单中心(三家ICU同一医院)、样本量有限。
对床旁实践的改变
- 对于静脉-动脉ECMO支持的难治性心源性休克患者,在成功撤机前可考虑拔管,拔管与更多无ICU天数相关,且不增加呼吸机相关性肺炎或30天死亡率。
- 拔管后需注意约25%的患者可能因呼吸、神经或血流动力学原因需要紧急再插管,应做好再插管准备。
- 入院时简化急性生理评分II较高的患者拔管可能性较低,临床决策时需综合考虑。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Although patients on venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock are usually supported with mechanical ventilation, it is not clear whether sedation cessation and extubation might improve outcomes.
DESIGN: Retrospective cohort study with propensity score overlap weighting analysis.
SETTING: Three ICUs in a 1,500-bed tertiary university hospital.
PATIENTS: From an overall cohort of 641 patients with venoarterial-extracorporeal membrane oxygenation support, the primary analysis was performed in 344 patients who had been successfully decannulated in order to reduce immortal time bias.
MEASUREMENTS AND MAIN RESULTS: Seventy-five patients (22%) were extubated during extracorporeal membrane oxygenation support and were subsequently decannulated alive. Forty-nine percent received noninvasive ventilation, and 25% had emergency reintubation for respiratory, neurologic, or hemodynamic reasons. Higher Simplified Acute Physiology Score II at admission (odds ratio, 0.97; 95% CI [0.95-0.99]; p = 0.008) was associated with a lower probability of extubation, whereas cannulation in cardiac surgery ICU (odds ratio, 3.14; 95% CI [1.21-8.14]; p = 0.018) was associated with an increased probability. Baseline characteristics were well balanced after propensity score overlap weighting. The number of ICU-free days within 30 days of extracorporeal membrane oxygenation decannulation was significantly higher among extubated patients compared with nonextubated patients (22 d [11-26 d] vs 18 d [7-25 d], respectively; p = 0.036). There were no differences in other outcomes including ventilator-associated pneumonia (odds ratio, 0.96; 95% CI [0.51-1.82]; p = 0.90) and all-cause mortality within 30 days of extracorporeal membrane oxygenation decannulation (5% vs 17%; hazard ratio, 0.54; 95% CI [0.19-1.59]; p = 0.27).As a secondary analysis, outcomes were compared in the overall cohort of 641 venoarterial extracorporeal membrane oxygenation-supported patients. Results were consistent with the primary analysis as extubated patients had a higher number of ICU-free days (18 d [0-24 d] vs 0 d [0-18 d], respectively; < 0.001) and a lower risk of death within 30 days of extracorporeal membrane oxygenation cannulation (hazard ratio, 0.45; 95% CI [0.29-0.71]; p = 0.001).
CONCLUSIONS: Extubation during venoarterial-extracorporeal membrane oxygenation support is safe, feasible, and associated with greater ICU-free days.
参考来源
- Massart N, Mansour A, Flecher E, et al. Clinical Benefit of Extubation in Patients on Venoarterial Extracorporeal Membrane Oxygenation. Crit Care Med. 2021. PMID: 34582413. doi:10.1097/CCM.0000000000005304
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。